World J Gastrointest Oncol (2019) 11(9):686704
Related Stories Semaglutide dose may matter more than weight loss for heart health GLP-1 drugs may reduce lung scarring from Long COVID in diabetic patients Semaglutide outperforms other GLP-1 drugs for weight loss in psychiatric populations Chemical modifications of native GLP-1 have since overcome this challenge, with several pharmacological GLP-1-derived drugs, including exenatide, liraglutide, lixisenatide, and most recently, semaglutide receiving regulatory approval for the treatment of T2D and obesity
The FDA-approved titration schedule starts at a low dose (0.25 mg weekly for Ozempic or Wegovy) to minimize gastrointestinal side effects, gradually increasing every four weeks
Specificity explains both therapeutic effects and safety, targeting relevant pathways without broadly disrupting cellular function
Mineral imbalance Overdosage of zinc may result in an imbalance in other minerals, such as copper, iron, and magnesium
Phenobarbital in Status epilepticus Rediscovery of an effective drug